Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia (CABP)

NCT01524302 is registered in ClinicalTrials.gov with Gary E. Stein, Pharm.D. as lead sponsor.

NCT NCT01524302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01524302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia (CABP)
Lead sponsor
Gary E. Stein, Pharm.D.
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2012
Completion date
April 30, 2015
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

community-acquired, pneumonia, bacterial